Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)

Abramson Cancer Center at Penn Medicine · with Fox Chase Cancer Center · NCT07471958

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
360
US sites recruiting
1
Study start
September 2, 2025
Record last updated
March 13, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of the study is to understand patient interest in telehealth and digital tools for pre-test genetic education and/or disclosure of genetic test results. Participants will receive telehealth genetic counseling in the home and may be offered various digital tools to help with the counseling and testing process. These are optional and participants can still speak with a genetic counselor if they wish.

Conditions: Cancer

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • 18 years of age or older
  • Speak and understand English
  • Meet current National Comprehensive Cancer Network (NCCN) or other national guidelines for germline genetic testing or are interested in genetic counseling based on personal or family history of cancer. Patients with prior genetic testing are eligible if they meet criteria for updated testing, or if post-test genetic counseling services are requested.

Exclusion Criteria

  • Communication difficulties such as:
  • Uncorrected or uncompensated hearing and/or vision impairment. Patients who can successfully use clinical assistance devices are not excluded.
  • Uncorrected or uncompensated speech defects. Patients who can successfully use clinical assistance devices are not excluded.
  • Uncontrolled psychiatric/mental condition or severe physical, neurological or cognitive deficits rendering individual unable to understand study goals and tasks

Recruiting US locations

  • Abramson Cancer Center at the University of Pennsylvania

    Philadelphia, PA 19104

    Site contact: Angela Bradbury, MD · 215-615-3341 · angela.bradbury@pennmedicine.upenn.edu

Study contacts (from the official record)

  • Angela Bradbury, MD · 215-615-3341 · angela.bradbury@pennmedicine.upenn.edu
  • Kelsey Karpink · 215-662-3531 · kelsey.karpink@pennmedicine.upenn.edu
Implementation of eHealth Delivery Alternatives for Cancer Genetic… (NCT07471958) | Bored Studies